Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Toronto Stock Exchange  >  Helix Biopharma Corp.    HBP   CA4229101098

HELIX BIOPHARMA CORP.

(HBP)
 SummaryQuotesChartsNewsCalendarCompany 
Quotes 5-day view   Delayed Quote. Delayed Toronto Stock Exchange
09/13/2019 09/16/2019 09/17/2019 09/19/2019 09/20/2019 Date
1.23(c) 1.2(c) 1.22(c) 1.25(c) 1.07(c) Last
3 751 34 747 8 760 61 293 5 975 Volume
-1.60% -2.44% +1.67% +2.46% -14.40% Change
More quotes
Company
Helix BioPharma Corp. is an immuno-oncology company, which specializes in the field of cancer therapy. The Company is developing products for the prevention and treatment of cancer based on its technologies. The Company's product development initiatives are focused primarily on technologies that... 
More about the company
Latest news on HELIX BIOPHARMA CORP.
09/03HELIX BIOPHARMA CORP. : and Moffit Cancer Centre to Present at World Molecular I..
AQ
08/21HELIX BIOPHARMA CORP. : Closes $7.0 Million Private Placement
AQ
08/08HELIX BIOPHARMA : Corps. Receives U.S. FDA Approval For Phase Ib/II Pancreatic T..
PU
08/07HELIX BIOPHARMA : Receives U.S. FDA Approval for Phase Ib/II Pancreatic Trial
AQ
07/24HELIX BIOPHARMA : to Present at RHK Capital Conference in New York
AQ
07/09HELIX BIOPHARMA : Crop. Submits L-DOS47 IND Application with U.S. FDA For Pancre..
PU
07/09HELIX BIOPHARMA CORP. : Submits L-DOS47 IND Application With U.S. FDA for Pancre..
AQ
06/11HELIX BIOPHARMA : Fiscal 3Q Earnings Snapshot
AQ
06/11HELIX BIOPHARMA CORP. : Announces Fiscal Third Quarter 2019 Results
AQ
05/31HELIX BIOPHARMA CORP. : Initiates OTCQB Application and Hires U.S. Investor Rela..
AQ
More news
Sector news : Biotechnology & Medical Research - NEC
09/20Brazil Announces Criminal Charges Against 7 Vale Employees in Dam Collapse--U..
DJ
09/20REGENERON PHARMACEUTICALS : Sanofi Get Positive CHMP Opinion for Dupixent
DJ
09/19Animal health sector aims to emulate Zoetis biotech leap
RE
09/18BIOGEN : to Study Higher Dose of Spinraza in Spinal Muscular Atrophy
DJ
09/16A Plan to Fight Hep C -- WSJ
DJ
More sector news : Biotechnology & Medical Research - NEC
Chart HELIX BIOPHARMA CORP.
Duration : Period :
Helix Biopharma Corp. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends HELIX BIOPHARMA CORP.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Managers
NameTitle
Heman Chao Director, Chief Executive & Scientific Officer
Slawomir Majewski Chairman
Photios Michalargias Chief Financial Officer
Marek Jan Orlowski Independent Director
Sylwester Cacek Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
HELIX BIOPHARMA CORP.135.85%101
IQVIA HOLDINGS INC33.94%30 481
LONZA GROUP35.89%25 846
CELLTRION, INC.--.--%18 845
INCYTE CORPORATION22.85%17 466
EXACT SCIENCES CORPORATION64.77%13 463